James A. Rickard

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin Carhart‐Harris, Mark Bolstridge, James Rucker et al. · The Lancet Psychiatry · 2016 · 1.5K citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +15

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Robin Carhart‐Harris, Mark Bolstridge, Camilla Day et al. · Psychopharmacology · 2017 · 973 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +15

RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis

James A. Rickard, Joanne A. O’Donnell, Joseph M. Evans et al. · Cell · 2014 · 587 citations · Full text

Life Sciences, Cell Biology, Immunology +11

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder

Ben Sessa, Laurie Higbed, Steve O’Brien et al. · Journal of Psychopharmacology · 2021 · 121 citations · Full text

Nursing, Pharmacotherapy, Psychiatry +17

Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease

Abhinav Vasudevan, Nina Parthasarathy, Danny Con et al. · Alimentary Pharmacology & Therapeutics · 2020 · 25 citations

Medicine, Pharmacology, Pharmacotherapy +15